Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity

• Annett Hessel,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Michael Schwendinger,

  Affiliation Department of Immunology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Georg W. Holzer,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Klaus K. Orlinger,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Sogue Coulibaly,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Helga Savidis-Dacho,

  Affiliation Department of Animal Models, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Marie-Luise Zips,

  Affiliation Department of Bacteriology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Brian A. Crowe,

  Affiliation Department of Immunology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Thomas R. Kreil,

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Hartmut J. Ehrlich,

  Affiliation Global R&D Vaccines, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• P. Noel Barrett,

  Affiliation Global R&D Vaccines, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯
• Falko G. Falkner

  * E-mail: falknef@baxter.com

  Affiliation Department of Virology, Baxter Bioscience, Biomedical Research Center, Orth/Donau, Austria

  ⨯